Zimmer Biomet Holdings Reports 4Q Loss
01 Febrero 2019 - 5:50AM
Noticias Dow Jones
By Max Bernhard
Zimmer Biomet Holdings Inc (ZBH) on Friday reported a loss in
the fourth quarter, hit by litigation and goodwill impairment
charges.
The Warsaw, Ind.-based medical-device company reported a
quarterly loss of $901.1 million, or $4.42 a share, compared with a
profit of $1.23 billion, or a $6.03 a share, for the same period
last year. Excluding items, Zimmer Biomet reported an adjusted
profit of $2.18 a share for the quarter, compared with $2.10 a
share last year and analysts' forecasts of $2.17 a share.
"The company's diluted loss per share included goodwill
impairment charges of $4.78 per share and legal charges of 59 cents
per share primarily related to a previously disclosed patent
litigation matter," the company said in a release.
Sales stayed flat at $2.07 billion.
Chief Executive Bryan Hanson said, "Overall, our financial
results for the full year were in-line with our expectations for
the progress of the turnaround of the business, and increase our
confidence in achieving our 2019 objectives."
Write to Max Bernhard at max.bernhard@dowjones.com;
@mxbernhard
(END) Dow Jones Newswires
February 01, 2019 06:35 ET (11:35 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Zimmer Biomet (NYSE:ZBH)
Gráfica de Acción Histórica
De Jul 2024 a Ago 2024
Zimmer Biomet (NYSE:ZBH)
Gráfica de Acción Histórica
De Ago 2023 a Ago 2024